Carbapenemase genes in clinical and environmental isolates of spp. from Quito, Ecuador.

PeerJ

Escuela de Ciencias Biológicas, Pontificia Universidad Católica del Ecuador, Quito, Ecuador.

Published: April 2024

Carbapenem-resistant spp. is associated with nosocomial infections in intensive care unit patients, resulting in high mortality. Although spp. represent a serious public health problem worldwide, there are a few studies related to the presence of carbapenemases in health care facilities and other environmental settings in Ecuador. The main aim of this study was to characterize the carbapenem-resistant spp. isolates obtained from four hospitals (52) and from five rivers (27) close to Quito. We used the disc diffusion and EDTA sinergy tests to determine the antimicrobial susceptibility and the production of metallo β-lactamases, respectively. We carried out a multiplex PCR of gene and the sequencing of partial gene to bacterial species identification. We performed molecular screening of nine carbapenem-resistant genes (, , , , , , , , and ) by multiplex PCR, followed by identification using sequencing of genes. Our findings showed that carbapenem-resistant were the main species found in health care facilities and rivers. Most of the clinical isolates came from respiratory tract samples and harbored , , , , , and genes. The river isolates harbored only the and probably genes. We concluded that the most predominant type of carbapenem genes among isolates were both and among clinical isolates.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11056107PMC
http://dx.doi.org/10.7717/peerj.17199DOI Listing

Publication Analysis

Top Keywords

carbapenem-resistant spp
8
health care
8
care facilities
8
multiplex pcr
8
clinical isolates
8
harbored genes
8
isolates
6
genes
5
carbapenemase genes
4
genes clinical
4

Similar Publications

Background: Metallo-beta lactamase resistance is one of the carbapenem resistances that worsen the world nowadays. A new variant of carbapenem-resistant has only limited reports from Africa including Ethiopia. This study aimed to determine Metallo -ß- lactamase resistance Gram-negative bacteria in Hawassa University Comprehensive Specialized Hospital January-June 2023.

View Article and Find Full Text PDF

Background: Meropenem-vaborbactam (MEM-VAB) is a novel carbapenem-beta-lactamase-inhibitor combination that demonstrates activity against carbapenem-resistant (CR) Gram-negative bacteria, and more specifically KPC-producers, since vaborbactam is an effective inhibitor of KPC enzymes in vitro. This study aimed to describe the initial uses and efficacy of MEM-VAB for compassionate treatment during the first 21 months following its early access in France.

Method: A national multicenter retrospective study was conducted, including all patients who received at least one dose of MEM-VAB between 20 July 2020, and 5 April 2022.

View Article and Find Full Text PDF

Data on the health impact of carbapenem-resistant bloodstream infections (CRE-BSIs) in pediatric populations from Latin America and the Caribbean (LAC) are limited. This systematic review aims to examine the demographic, clinical, and microbiological aspects and resource utilization of this infection in children from this region. This systematic review investigates the impact of CRE-BSIs in pediatric populations across LAC.

View Article and Find Full Text PDF

Prevalence of difficult-to-treat resistance in ESKAPE pathogens in a third level hospital in Mexico.

Infect Prev Pract

March 2025

Department of Infectious Diseases, Hospital Universitario "Dr. José E. González" y Facultad de Medicina, Universidad Autónoma de Nuevo León, Mitras Centro, Monterrey, Nuevo León, CP 64460, México.

Background: Antimicrobial resistance and difficult-to-treat resistance (DTR) in ESKAPE pathogens ( and species) is a threat to human health. The aim of this study was to determine the prevalence of antimicrobial resistance and DTR rates in ESKAPE pathogens over six years in a third-level hospital from Monterrey, Mexico.

Methods: Antimicrobial susceptibility testing was determined by either disk diffusion or broth microdilution in strains from 2018 to 2023.

View Article and Find Full Text PDF

Molecular epidemiology of carbapenem-resistant group in Taiwan.

mSphere

December 2024

Department of Microbiology and Immunology, School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.

particularly the group, is a major cause of nosocomial infections, and carbapenem-resistant spp. are important human pathogens. We collected 492 spp.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!